Sickle Cell Anemia Research - Genetics, Causes, Symptoms

Sickle Cell Anemia Research Today is a free monthly online journal that collates and summarizes the latest research about Sickle Cell Anemia, including details on genetics, causes, symptoms.


Sickle Cell Anemia Research Today

Home

View Latest Issue

Information About Sickle Cell Anemia

Books on Sickle Cell Anemia

Advertising in Research Today

View Other Research Today Publications



Microarray analysis of liver gene expression in iron overloaded patients with sickle cell anemia and beta-thalassemia.

Flanagan JM, Steward S, Hankins JS, Howard TM, Neale G, Ware RE

Department of Hematology, St Jude Children's Research Hospital, Memphis, Tennessee 38105, USA. jonathan.flanagan@stjude.org

Chronic transfusion therapy is used clinically to supply healthy erythrocytes for patients with sickle cell anemia (SCA) or beta-thalassemia major (TM). Despite the benefits of red blood cell transfusions, chronic transfusions lead to iron accumulation in key tissues such as the heart, liver, and endocrine glands. Transfusion-acquired iron overload is recognized as a cause of morbidity and mortality among patients receiving chronic transfusions. At present, there is little understanding of molecular events that occur during transfusional iron loading and the reasons for the large inter-individual variation observed clinically in transfusion-acquired iron accumulation. To address these issues, we examined whether any liver-expressed genes in SCA or TM patients with transfusional iron overload were associated with the degree of iron accumulation. Specifically, we performed microarray analysis on liver biopsy specimens comparing SCA patients with mild or severe iron overload and also compared SCA with TM patients. Fifteen candidate genes were identified with significantly differential expression between the high and low liver iron concentrations. SCA patients and 20 candidate genes were detected between the SCA and TM patient comparison. Subsequent quantitative PCR experiments validated 12 candidate genes; with GSTM1, eIF5a, SULF2, NTS, and HO-1 being particularly good prospects as genes that might affect the degree of iron accumulation. Future work will determine the baseline expression of these genes prior to transfusional iron overload and elucidate the full impact of these genes on the inter-individual variation observed clinically in transfusion-acquired iron accumulation.

Published 1 June 2009 in Am J Hematol, 84(6): 328-34.
Full-text of this article is available online (may require subscription).

Place a permanent text-link or advertisement here for just US$15.

© 2006-2010 Sickle Cell Anemia Research Today. All Rights Reserved.



Sickle Cell Anemia Research Today Archive:

Volume 1 (2006)
  Issue 1 (February)
  Issue 2 (March)
  Issue 3 (April)
  Issue 4 (May)
  Issue 5 (June)
  Issue 6 (July)
  Issue 7 (August)
  Issue 8 (September)
  Issue 9 (October)
  Issue 10 (November)
  Issue 11 (December)

Volume 2 (2007)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 3 (2008)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 4 (2009)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 5 (2010)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)



Sickle Cell Anemia Books

Sickle Cell Anemia (Diseases and People)

Sickle Cell Anemia (Diseases and People)